BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3816202)

  • 1. Oral substitution in patients sensitized by transdermal clonidine treatment.
    Maibach HI
    Contact Dermatitis; 1987 Jan; 16(1):1-8. PubMed ID: 3816202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine: irritant and allergic contact dermatitis assays.
    Maibach H
    Contact Dermatitis; 1985 Apr; 12(4):192-5. PubMed ID: 4017566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension by a new transdermal form of clonidine.
    Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
    J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal clonidine application: long-term results in essential hypertension.
    Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
    Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis from a clonidine transdermal delivery system.
    Corazza M; Mantovani L; Virgili A; Strumia R
    Contact Dermatitis; 1995 Apr; 32(4):246. PubMed ID: 7600788
    [No Abstract]   [Full Text] [Related]  

  • 7. Rebound hypertension associated with transdermal clonidine and contact dermatitis.
    White TM; Guidry JR
    West J Med; 1986 Jul; 145(1):104. PubMed ID: 3751022
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing the contact dermatitis caused by a transdermal clonidine patch.
    McChesney JA
    West J Med; 1991 Jun; 154(6):736. PubMed ID: 1877221
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension.
    Houston MC; Hays L
    Am Heart J; 1993 Oct; 126(4):918-23. PubMed ID: 8213450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebound hypertension during initiation of transdermal clonidine.
    Stewart M; Burris JF
    Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance].
    Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF; Graif JL; Husebye DG; Maddy MM; McArthur CD; Path MJ; O'Connell MB; Iber C; Davidman M
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient acceptance of transdermal clonidine. A retrospective review of 25 patients.
    Chen SW; Vidt DG
    Cleve Clin J Med; 1989; 56(1):21-6. PubMed ID: 2731324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
    Kellaway GS; Lubbe WF
    N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal clonidine: therapeutic considerations.
    Sica DA; Grubbs R
    J Clin Hypertens (Greenwich); 2005 Sep; 7(9):558-62. PubMed ID: 16227779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal clonidine in young and elderly patients with mild hypertension: evaluation by three noninvasive methods of blood pressure measurement.
    Jeunemaitre X; Ged E; Ducrocq MB; Alhenc-Gelas F; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):162-7. PubMed ID: 2441166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.